These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33372730)

  • 61. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uptake of services for prevention of mother-to-child transmission of HIV in a community cohort in rural Tanzania from 2005 to 2012.
    Gourlay A; Wringe A; Todd J; Cawley C; Michael D; Machemba R; Clark B; Masesa C; Marston M; Urassa M; Zaba B
    BMC Health Serv Res; 2016 Jan; 16():4. PubMed ID: 26739028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acceptability of community-based mentor mothers to support HIV-positive pregnant women on antiretroviral treatment in western Kenya: a qualitative study.
    Wanga I; Helova A; Abuogi LL; Bukusi EA; Nalwa W; Akama E; Odeny TA; Turan JM; Onono M
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):288. PubMed ID: 31409297
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
    Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
    Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV-1 Early Infant Diagnosis is an Effective Indicator of the Prevention of Mother-to-Child Transmission Program Performance: Experience from Cameroon.
    Saounde Temgoua EM; Nkenfou CN; Zoung-Kanyi Bissek AC; Fokam J; Billong SC; Sosso SM; Tangipumdu C; Elong EL; Domkan I; Colizzi V
    Curr HIV Res; 2015; 13(4):286-91. PubMed ID: 25845391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
    Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
    Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.
    Price AJ; Kayange M; Zaba B; Chimbwandira FM; Jahn A; Chirwa Z; Dasgupta AN; Katundu C; Saul JL; Glynn JR; Koole O; Crampin AC
    Sex Transm Infect; 2014 Jun; 90(4):309-14. PubMed ID: 24714445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.
    Rempis EM; Schnack A; Decker S; Braun V; Rubaihayo J; Tumwesigye NM; Busingye P; Harms G; Theuring S
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):82. PubMed ID: 28270119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.
    Chetty T; Thorne C; Tanser F; Bärnighausen T; Coutsoudis A
    BMJ Open; 2016 Oct; 6(10):e012088. PubMed ID: 27798004
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    Ngemu EK; Khayeka-Wandabwa C; Kweka EJ; Choge JK; Anino E; Oyoo-Okoth E
    BMC Res Notes; 2014 Jan; 7():52. PubMed ID: 24447387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
    Rupérez M; Noguera-Julian M; González R; Maculuve S; Bellido R; Vala A; Rodríguez C; Sevene E; Paredes R; Menéndez C
    PLoS One; 2018; 13(5):e0196451. PubMed ID: 29742132
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Implementation and Operational Research: Distance From Household to Clinic and Its Association With the Uptake of Prevention of Mother-to-Child HIV Transmission Regimens in Rural Zambia.
    Escamilla V; Chibwesha CJ; Gartland M; Chintu N; Mubiana-Mbewe M; Musokotwane K; Musonda P; Miller WC; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e94-e101. PubMed ID: 26470035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
    Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
    PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progress Toward Eliminating Mother to Child Transmission of HIV in Kenya: Review of Treatment Guidelines Uptake and Pediatric Transmission Between 2013 and 2016-A Follow Up.
    Pricilla RA; Brown M; Wexler C; Maloba M; Gautney BJ; Finocchario-Kessler S
    Matern Child Health J; 2018 Dec; 22(12):1685-1692. PubMed ID: 30047080
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incidence of antiretroviral adverse drug reactions in pregnant women in two referral centers for HIV prevention of mother-to-child-transmission care and research in Rio de Janeiro, Brazil.
    Santini-Oliveira M; Friedman RK; Veloso VG; Cunha CB; Pilotto JH; Marins LM; João EC; Torres TS; Grinsztejn B
    Braz J Infect Dis; 2014; 18(4):372-8. PubMed ID: 24662139
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pregnant women's retention and associated health facility characteristics in the prevention of mother-to-child HIV transmission in Indonesia: cross-sectional study.
    Lumbantoruan C; Kelaher M; Kermode M; Budihastuti E
    BMJ Open; 2020 Sep; 10(9):e034418. PubMed ID: 32973049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.